Levomethadyl Acetate [Usan]
Brand names,
Levomethadyl Acetate [Usan]
Analogs
Levomethadyl Acetate [Usan]
Brand Names Mixture
Levomethadyl Acetate [Usan]
Chemical_Formula
C23H31NO2
Levomethadyl Acetate [Usan]
RX_link
http://www.rxlist.com/cgi/generic2/levomethadyl.htm
Levomethadyl Acetate [Usan]
fda sheet
Levomethadyl Acetate [Usan]
msds (material safety sheet)
Levomethadyl Acetate [Usan]
Synthesis Reference
No information avaliable
Levomethadyl Acetate [Usan]
Molecular Weight
353.498 g/mol
Levomethadyl Acetate [Usan]
Melting Point
No information avaliable
Levomethadyl Acetate [Usan]
H2O Solubility
>15 mg/mL
Levomethadyl Acetate [Usan]
State
Solid
Levomethadyl Acetate [Usan]
LogP
6.139
Levomethadyl Acetate [Usan]
Dosage Forms
Solution
Levomethadyl Acetate [Usan]
Indication
LAAM is indicated for the treatment and management of opiate dependence. It is sometimes used to treat severe pain in terminal patients.
Levomethadyl Acetate [Usan]
Pharmacology
LAAM is a synthetic synthetic opioid analgesic with multiple actions quantitatively similar to those as morphine, the most prominent of which involve the central nervous system and organs composed of smooth muscle. However, LAAM is more active and more toxic than morphine. The principal actions of therapeutic value are analgesia and sedation and detoxification or temporary maintenance in narcotic addiction. The LAAM abstinence syndrome, although qualitatively similar to that of morphine, differs in that the onset is slower, the course is more prolonged, and the symptoms are less severe.
Levomethadyl Acetate [Usan]
Absorption
LAAM is rapidly absorbed from an oral solution.
Levomethadyl Acetate [Usan]
side effects and Toxicity
Signs of overdose include apnea, circulatory collapse, pulmonary edema, cardiac arrest, and death.
Levomethadyl Acetate [Usan]
Patient Information
No information avaliable
Levomethadyl Acetate [Usan]
Organisms Affected
Humans and other mammals